Sort
21,453 grants matching “tuberculosis”
STUDIES OF M TUBERCULOSIS SURVIVAL IN ANIMAL MODELS
$429,212Public Health Research Institute · R01 · FY2001 · HL
Innate Determinants of Microbial Immunity
$429,118Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
SBIR Phase II: Early Growth Metabolic Responses of Mycobacteria
$429,080Ronald J Rieder · Biosense Technologies Inc. · · FY2008 · TIP
Molecular mechanisms used by Chlamydia trachomatis to manipulate membrane fusion
$429,000Fabienne Michelle Paumet · Thomas Jefferson University · R01 · FY2018 · AI
Molecular mechanisms used by Chlamydia trachomatis to manipulate membrane fusion
$429,000Fabienne Michelle Paumet · Thomas Jefferson University · R01 · FY2017 · AI
Glutathione depletion in the CNS and its effects on Mtb infection
$429,000Vishwanath Venketaraman · Western University Of Health Sciences · R15 · FY2024 · HL
ANTIMYCOBACTERIAL MECHANISMS OF APOPTOSIS IN THE LUNG
$428,882Univ Of Massachusetts Med Sch Worcester · R01 · FY2005 · HL
The role of TIM-3 in regulating T cell function during tuberculosis
$428,728Samuel M Behar · Brigham And Women'S Hospital · P01 · FY2016 · AI
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
$428,706William Robert Jacobs · Albert Einstein College Of Medicine · R24 · FY2018 · AI
UPLC with Tandem MS for Sensitive Quantitative Analysis of Small Molecules
$428,606Michelle A Rudek · Johns Hopkins University · S10 · FY2010 · RR
Genetic Analysis of Histoplasma-Macrophage Interactions
$428,560Anita Sil · University Of California Berkeley · P01 · FY2007 · AI
African Programe for Training in HIV/TB Research
$428,553Peter R Mason · Biomedical Research & Training Institute · U2R · FY2009 · TW
Tuberculosis Elimination and Laboratory control Cooperative Agreement
$428,534Jennifer Cochran · Massachusetts State Dept Of Pub Health · U52 · FY2016 · PS
Monoclonal antibody passive vaccination to treat XDR Acinetobacter infections
$428,216Brad J Spellberg · University Of Southern California · R56 · FY2014 · AI
Genetic Control of Pulmonary Cavities in Tuberculosis
$428,076University Of Texas Hlth Sci Ctr Houston · R01 · FY2005 · HL
Substrate Activity Screening: A New Approach to Inhibitor Discovery
$428,042Jonathan A. Ellman · Yale University · R01 · FY2011 · GM
Molecular Interactions Of Lymphoid Cell Receptors
$428,036David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
ALASKA TUBERCULOSIS ELIMINATION AND LABORATORY
$427,966Elizabeth Funk · Alaska State Department Of Hlth-Soc Svcs · U52 · FY2010 · PS
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
$427,901Adithya Cattamanchi · University Of California-Irvine · R01 · FY2025 · HL
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
$427,883Volker Briken · Univ Of Maryland, College Park · R01 · FY2009 · AI
African Programe for Training in HIV/TB Research
$427,803Peter R Mason · Biomedical Research & Training Institute · U2R · FY2008 · TW
Substrate Activity Screening: A New Approach to Inhibitor Discovery
$427,789Jonathan A. Ellman · Yale University · R01 · FY2012 · GM
Human airway microfold cells in mucosal immunity to bacterial pathogens
$427,748Michael Shiloh · Ut Southwestern Medical Center · U01 · FY2020 · AI
Intron endonucleases and inteins
$427,743Marlene Belfort · Wadsworth Center · R01 · FY2009 · GM
Project 3. Defining the RNA processing and degradation pathways of Mtb.
$427,698Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI